Long lasting synthetic glucagon-like peptide {GLP-1}
First Claim
Patent Images
1. The compound D-Ala8 GLP-1 (7-36)-Lys37(ε
- -(AEEA)-MPA)-NH2.
3 Assignments
0 Petitions
Accused Products
Abstract
Modified insulinotropic peptides are disclosed. The modified insulinotropic peptides are capable of forming a peptidase stabilized insulinotropic peptide. The modified insulinotropic peptides are capable of forming covalent bonds with one or more blood components to form a conjugate. The conjugates may be formed in vivo or ex vivo. The modified peptides are administered to treat humans with diabetes and other related diseases.
130 Citations
9 Claims
-
1. The compound D-Ala8 GLP-1 (7-36)-Lys37(ε
- -(AEEA)-MPA)-NH2.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
Specification